13D Filing: Longitude Capital Partners, LLC and Corcept Therapeutics Inc (CORT)

Page
8 of 10 Pages

(b) LVP, LCA and LCP
have shared power to vote and dispose of 1,767,717 shares of Common Stock. Ms. Bakker and Mr. Enright, managing directors
of LCP, may be deemed to have shared voting and dispositive power with respect to all such shares. In addition, Ms. Bakker
and Mr. Enright have shared dispositive and voting power with respect to 305,000 shares of Common Stock subject to stock options
that are currently exercisable or exercisable within 60 days after June 7, 2017, which were granted to Mr. Enright as
consideration for his service as a director on the Board. Ms. Bakker and Mr. Enright have sole dispositive and voting
power over 171,610 and 272,281 shares of Common Stock, respectively, which are held directly by each of them.

(c) Except as reported
in this Amendment, no Reporting Person has effected any transactions in the Issuer’s securities during the 60-day period
ended on June 7, 2017, the date of the last transaction reported in this Amendment.

(e) As of June 7,
2017, each of the Reporting Persons ceased to be a beneficial owner of more than 5% of the Common Stock.

Item 6 of the Schedule is amended
by incorporating the information set forth in Item 4 of this Amendment.